Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 14:2020:7373498.
doi: 10.1155/2020/7373498. eCollection 2020.

A Review of Nutrients and Compounds, Which Promote or Inhibit Intestinal Iron Absorption: Making a Platform for Dietary Measures That Can Reduce Iron Uptake in Patients with Genetic Haemochromatosis

Affiliations

A Review of Nutrients and Compounds, Which Promote or Inhibit Intestinal Iron Absorption: Making a Platform for Dietary Measures That Can Reduce Iron Uptake in Patients with Genetic Haemochromatosis

Nils Thorm Milman. J Nutr Metab. .

Abstract

Objective: To provide an overview of nutrients and compounds, which influence human intestinal iron absorption, thereby making a platform for elaboration of dietary recommendations that can reduce iron uptake in patients with genetic haemochromatosis.

Design: Review. Setting. A literature search in PubMed and Google Scholar of papers dealing with iron absorption.

Results: The most important promoters of iron absorption in foods are ascorbic acid, lactic acid (produced by fermentation), meat factors in animal meat, the presence of heme iron, and alcohol which stimulate iron uptake by inhibition of hepcidin expression. The most important inhibitors of iron uptake are phytic acid/phytates, polyphenols/tannins, proteins from soya beans, milk, eggs, and calcium. Oxalic acid/oxalate does not seem to influence iron uptake. Turmeric/curcumin may stimulate iron uptake through a decrease in hepcidin expression and inhibit uptake by complex formation with iron, but the net effect has not been clarified.

Conclusions: In haemochromatosis, iron absorption is enhanced due to a decreased expression of hepcidin. Dietary modifications that lower iron intake and decrease iron bioavailability may provide additional measures to reduce iron uptake from the foods. This could stimulate the patients' active cooperation in the treatment of their disorder and reduce the number of phlebotomies.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflicts of interest.

Figures

Figure 1
Figure 1
Mechanisms of intestinal iron absorption. Most iron is absorbed in the duodenum and proximal jejunum due to the acidic pH of the intestinal content. More, distally in the jejunum, pH becomes neutral or alkaline, and iron uptake declines. Nonheme food iron Fe3+ enters the nonheme iron pool and heme iron enters the heme iron pool. Fe3+ is reduced to Fe2+ by duodenal cytochrome B and subsequently enters the luminal side of the enterocyte by the iron importer DMT-1 pathway. Fe2+ is transferred to the basolateral side of the enterocyte, effluxed by the iron exporter ferroportin, and subsequently oxidized to Fe3+ by hephaestin and transferred to the carrier protein transferrin in the blood plasma. Part of the iron enters the intracellular ferritin iron pool and is lost by desquamation of the enterocyte into faeces. Hepcidin from the liver inactivates ferroportin, thereby inhibiting iron uptake. Heme iron is absorbed within the intact protoporphyrin ring by a separate pathway possibly involving a heme transporter and heme oxygenase. Figure adapted with permission from [27].

Similar articles

Cited by

References

    1. Lynch S., Skikne B., Cook J., Cook Food iron absorption in idiopathic hemochromatosis. Blood. 1989;74(6):2187–2193. doi: 10.1182/blood.v74.6.2187.2187. - DOI - PubMed
    1. Walters G. O., Jacobs A., Worwood M., Trevett D., Thomson W. Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration. Gut. 1975;16(3):188–192. doi: 10.1136/gut.16.3.188. - DOI - PMC - PubMed
    1. Moretti D., van Doorn G. M., Swinkels D. W., Melse-Boonstra A. Relevance of dietary iron intake and bioavailability in the management of HFE hemochromatosis: a systematic review. The American Journal of Clinical Nutrition. 2013;98(2):468–479. doi: 10.3945/ajcn.112.048264. - DOI - PubMed
    1. Milman N. T., Schioedt F. V., Junker A. E., Magnussen K. Diagnosis and treatment of genetic HFE-hemochromatosis: the Danish aspect. Gastroenterology Research. 2019;12(5):221–232. doi: 10.14740/gr1206. - DOI - PMC - PubMed
    1. Milman N., Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the vikings. Clinical Genetics. 2003;64(1):36–47. doi: 10.1034/j.1399-0004.2003.00083.x. - DOI - PubMed

LinkOut - more resources